🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

3/ Also these #ASCO25 #mmsm titles: Elranatanab + Dara MagnetisMM-6 part 1 Thanos Dimopoulos meetings.asco.org/abstracts-pres…   JNJ-5322 trispecific meetings.asco.org/abstracts-pres…   Checkpoint inhibitors and radiation for EMD Noa Biran meetings.asco.org/abstracts-pres…

Getting closer and closer to personalization of myeloma therapy very elegantly discussed by Dr N Munshi at ⁦COMy⁩ ⁦Myeloma Society⁩ ⁦IACH⁩

By ⁦nizar jacques bahlis⁩ at the ⁦COMy⁩ ⁦IACH⁩

Right time: stopping multiple myeloma maintenance #mmsm #bmtsm Philip McCarthy Blood Journal ashpublications.org/blood/article/…

The last castle has fallen. First positive phase III IO clinical trial in ovarian cancer!!!! Could PARPi resistance prime for IO efficacy? IO-ADCs combos seem the next rationale apprach for this disease setting. OncoAlert ESGO ΕΟΠΕ merck.com/news/merck-ann…

15 Years Since We Changed Myeloma Care with Less Dexamethasone - Vincent Rajkumar Vincent Rajkumar ECOG-ACRIN Cancer Research Group oncodaily.com/science/vincen… #Cancer #CancerResearch #Medicine #Health #MedX #MedNews #MedEd #Dexamethasone #MyelomaCare #Oncology #OncoDaily

Jean Luc awards his award to Sagar Lonial from Emory

The final CoMy award my long term friend who with us in London and the IFM did the first trials of ASCT in MM congrats To Jean Paul Fermand

Thank you very much.

'Less is more' maintenance therapy in #MultipleMyeloma! Triplets→ASCT→3yr Len → D/C if MRD-neg (NGF+PET/CT-neg) Results: 3yr PFS ~93%, TFS ~75% *Treatment initiated for MRD resurgence Based on Ben Derman 's MRD2STOP + this data: I'm comfortable stopping Len in standard-risk

And congrats to you my friend for receiving the Women in Myeloma Achievement Award.!

Another very important topic elegantly discussed by Dr ⁦Joshua Richter, MD, FACP⁩ at the ⁦COMy⁩ ⁦IACH⁩

Another study from our group on AL amyloidosis under the leadership of Stathis Kastritis onlinelibrary.wiley.com/doi/10.1002/aj…

Honored to give a keynote lecture on how to approach cure in WM:lessons from MM Great discussions with Steve Treon,Christian Buske Stathis Kastritis and others

Love this thread!! #mmsm 👌🏾

Second day of the 10th meeting of the European consortium of Waldenstrom Macroglobulinemia.Brainstorming :how can we translate insights of biology into clinical approaches?

Great news! FDA ODAC panel voted 6–2 YES on: “Do AQUILA trial results support a favorable benefit-risk for Dara-SC in high-risk smoldering myeloma?” IMF SAB members Drs. Vincent Rajkumar & Sagar Lonial MD shared expert insights. Learn more: mmsm.link/4kujklH

Ξεκινάει σήμερα στην Πάτρα το Πανελλήνιο Συνέδριο Ενδοκρινολογίας, Μεταβολισμού και Σακχαρώδη Διαβήτη! Θα έχω την τιμή να μιλήσω αύριο για την ενδοκρινολογική τοξικότητα μετά από ανοσοθεραπεία. Έχω συμμετάσχει στη συγγραφή των σχετικών διεθνών κατευθυντήριων οδηγιών!

2/3: It was published in J Neurochem because the dogma at the time was that proteases were small proteins. Major journals to which Wilk & Orlowski submitted their work (ie. Science) would not accept that there was such a large particle that had proteolytic capacity & rejected it.

This is what drives all of us in academia. The opportunity to make a difference for patients around the world and improve the lives of patients with cancer and other diseases.